IMPORTANT DISCLAIMER Variant View Research and/or its affiliates actively manage trading accounts and may take positions in securities mentioned in its publications or the derivatives of those securities. Variant View Research and/or its affiliates may change its positions at any time without disclosure. We have a financial interest via our securities positions, but we do not receive direct monetary compensation for writing or publishing articles. Information and opinions provided in our publications are compiled from or arrived at from sources believed to be reliable, however no representation or warranty, express or implied, is made as to their accuracy or completeness. In the event that we receive conflicting information subsequent to publication, we may not necessarily disclose such information or update our publications. Our publications are provided for informational purposes only and do not constitute investment advice. Investing in securities involves a high degree of risk, and investment activity should only be undertaken after consulting a professional investment adviser.
Full-time investor. Formerly buy-side credit analyst (2yrs) covering Japanese + Asian companies. Before that, I was a cross asset derivatives salesperson at a large bulge-bracket firm, based in Tokyo (4yrs). I use Seeking Alpha to clarify and synthesize my investment thought process and to elicit feedback on my theses; additionally I like to connect with other investors and swap ideas.
You can read my finance-related blog at rapercapital.com (less organized than Seeking Alpha writeups, more my random musings on various finance-related topics).
Going forward I will try to tweet my investment-related thoughts/updates to articles/etc. You can follow me on Twitter, my handle is @puppyeh1
Always looking for new ideas across the board. Happy to exchange ideas/share thoughts/swap notes, feel free to private message me. I currently live in Singapore.
Charles Rotblut, CFA is the editor of the AAII Journal, the flagship publication of The American Association of Individual Investors (AAII). Charles provides both insight about individual investor sentiment and market analysis. He is also the author of "Better Good than Lucky: How Savvy Investors Create Fortune with the Risk-Reward Ratio" (W&A Publishing/Trader's Press).
I have retired from a 35 years career in the semiconductor industry. I now have the time to do the deep research necessary for successful investing.
I freely provide investment information for friends and family.
I am a member of MENSA, which means precisely nothing except I wake up in the middle of the night doing pointless math problems in my head:)
Gravity Research is an organization composed of financial analysts with experience working at top investment banks and buyside firms as well as industry veterans who are experts in their fields. We engage in careful research on publicly traded companies that we believe offer compelling long or short investment opportunities, and present our best ideas to the public.
Long/short equity investor working as a professional manager for 15 years. Long-term value investor focused on catalyst-driven ideas. Utilize investigative journalism techniques and deep dive accounting focus to uncover interesting shorts.
Suhail Capital Management is a Cayman Domiciled Private Investment Firm. We focus on event driven long/short opportunities in what we believe to be seriously mispriced global listed securities.
Edward Roche is the President of Freedom Mountain Investments (http://www.freedommount.com/), an investment firm founded in 2006, located in Paoli, Pennsylvania. Freedom Mountain specializes in identifying hidden value in small and mid size companies before they are recognized by the market. The investment approach is based upon fundamental analysis and places a high emphasis on real and rising financials including sales and earnings. One special approach used to identify a catalyst for release of value is the “Venerable Owner” strategy. This strategy tracks all companies where an older owner owns 40% or more of a company. These situations often lead to sale of the company at a significant premium to market value when the owner seeks to retire. Edward Roche received a Ph. D. degree in Polymer Science and Engineering from the University of Massachusetts and earned an MBA in Finance from the Haub School of Business, St. Joseph’s University, Philadelphia PA. He recently completed a career at the McNeil division of Johnson & Johnson that included high level positions in Business Development and R&D. He is the inventor on 15 US patents in the area of drug delivery and has authored ten scientific publications.
Gotham City Research LLC focuses on due diligence-based, special situation investing. As of the publication date of our articles, we may have long or short equity positions in the companies covered. http://www.gothamcityresearch.com
The Fraud Research Institute ("FRI") specializing in the research and discovery of financial scandals and corporate malpractice in the United States with an emphasis on the small cap markets.
Our business model is to publish the highest quality and most compelling professional research reports that highlight all material information necessary for short-biased traders to identify superior risk-to-reward trade ideas that are primarily a result of market inefficiencies created by the artificial demand from stock promotion (pump & dump) campaigns.
We identify Wall Street's biggest frauds and profit from them.
"Nishkama Capital LLC ("Nishkama") is an investment manager with a long / short equity strategy with a focus in the Technology, Media and Telecom (“TMT”) sectors. Nishkama also makes investments in other sectors such as Consumer, Industrials and Financials. The Founder is the Author of "The Emotionally Intelligent Investor: How Self-Awareness, Empathy and Intuition Drive Performance."
I am an activist investor in US and Chinese stocks. I was previously an investment banker in New York Hong Kong and London for 9 years, focused on Equity Capital Markets. I look at both long ideas and short ideas and typically focus on a small number on names where I can spend the time to conduct very deep research. I spend my time living between Los Angeles and Beijing, China.
I am currently an individual investor with focus on event-driven trading and long-short opportunities. I graduated Emory University in 2009 and am also a finance Phd dropout from UCLA Anderson. I could be reached at firstname.lastname@example.org
I work for a small long/short, value-oriented investment partnership. On the long side, we prefer to invest in high quality businesses that possess discernible competitive moats, which operate in industries with reliable, growing end markets. For short positions, we generally look for companies that operate in highly competitive markets with low barriers to entry. We also specialize in "special situation" shorts, which may include circumstances where we believe a company's management team has misled investors about business prospects or where the market has misread certain corporate developments.
The founding members of Chimera Research Group have over 50 years of combined experience in the biotech and pharmaceutical sector. Their experience includes work at Investment Banks, Hedge Funds, Pharmaceutical Companies, top-tier Universities, and the U.S. Food and Drug Administration (FDA). Their published work includes freelance and editorial contributions both print and on-line, clinical and medical research, books and tutorials, as well as contributions to on-line social media. Through these and other activities they were able to collaborate and connect amongst themselves to establish this cadre of like-minded biotech/pharma trading and investing aficionados.
The Team includes:
Chief Scientific Analyst - Jason Chew
Chief Research Analyst - Patrick Crutcher
Chief Medical Analyst - Dr. Tro Kalayjian
CEO & Trading Analyst - Tony Pelz
Research Analyst - Dr. Andrew Goodwin
Research Analyst - Dr. Juan Pedro Rodríguez Serrate
Technical Analyst - Joe Gantoss
Research Analyst - Dr. Steven Murphy
Gray Wolf Research is the pseudonym of a research team focusing on publicly traded equities. As of the publication date of our articles, we may have long or short equity positions in the companies covered. We do not use options to establish positions prior to a report’s publication. We do not discuss unpublished reports, or provide any advanced warning of future reports to others. Due to the danger of retaliation from company management, our reports are written under a pseudonym.
One of the first stocks Michael Goode looked to invest in when he first started investing in 2005 was a small company traded on the Pinksheets called US WindFarming. During his research, Michael found out that the CEO had previously been convicted of criminal stock fraud and had served time in jail for a scheme that purported to turn base metals into gold. Michael decided not to invest and six months later the SEC sued the company, alleging that all the press releases were fake and the company was a sham that existed for the sole purpose of selling shares to gullible investors in order to enrich the insiders.
Following that experience, Michael Goode became a bit of a cynic. While he called himself a value investor and even briefly ran a value investing newsletter, his true love was exposing fraud and failed businesses. At his blog GoodeValue.com, sometimes syndicated on SeekingAlpha.com, he blasted companies such as H2Diesel (later renamed New Generation Biofuels), Cytocore (later sued by the SEC), Remote MDX (later panned by Andrew Left of Citron Research and Carol Remond of Dow Jones Newswires), and Noble Roman’s Pizza (on which he was quoted in multiple articles in the Indianapolis Business Journal).
Michael Goode has continued to shine a light on stock promotions and the people behind them on his trading blog, GoodeTrades.com. He has blogged about lawsuits involving stock promoters (a couple more) and he has exposed the multiple websites used by certain stock promoters. He remains a full-time stock trader; you can see most of his trades on Profit.ly.
Michael Goode graduated from Earlham College in 2004 and obtained a Masters Degree in Cognitive Psychology in 2007, from Washington University in St. Louis. He is the managing member of MorningLightMountain LLC, the owner of GoodeTrades.com, OTCMicroCapResearch.com, and all other content he writes online. Michael Goode has never been charged with or convicted of any crime whatsoever.